Publication | Open Access

BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma

Nras MutationOncologyBraf MutationMedicineMelanomaImmunologyPathologyCancer GenomicsStage Iii MelanomaImmunotherapyMolecular DiagnosticsTumor BiologySkin Cancer